People In Brief
This article was originally published in The Gray Sheet
Executive Summary
NovoStent gets new CEO: Ray Martin, PhD, will replace the firm's founder and primary inventor, Michael Hogendijk, as President & CEO. Hogendijk will continue as chief technical officer. Martin was most recently VP-business development of TriVascular, which was acquired by Boston Scientific in April. He also has held executive positions at Bard and W.L. Gore, where he co-invented the Gore Viabahn and Hemobahn stent grafts. NovoStent recently raised $3.1 mil. for its first human trial evaluating its self-expanding helical stent in the superficial femoral artery, scheduled to start in 2006 (1"The Gray Sheet" Sept. 5, 2005, p. 14)...
You may also be interested in...
Financings In Brief
Adiana: Non-incisional, permanent contraceptive manufacturer will use the proceeds from a $23 mil. Series D financing to complete its pivotal clinical trial, obtain PMA approval and prepare for market launch. The funding was led by Tullis-Dickerson & Co., with OrbiMed Advisors LLC joining as a new investor. Both venture capital firms will be represented on the firm's board of directors, according to Adiana. The company expects to pursue a PMA for the device in early 2006, after completing a 600-patient, 16-site clinical trial. Once approved, Adiana will compete with Conceptus' Essure non-incisional permanent birth-control device(1"The Gray Sheet" Dec. 6, 2004, p. 24)...
People In Brief
Rita Medical: Fremont, Calif. company engages executive search firm Stuart Spencer to assist in recruiting new CFO to replace outgoing exec Donald Stewart, who plans to resign as soon as a suitable substitute is found. Stewart served as Rita's interim CEO during 2003 and was a senior member of the firm's integration team during its merger with Horizon Medical Products last year (1"The Gray Sheet" May 17, 2004, p. 21). Rita sells radiofrequency ablation systems using disposable needles under the Starburst brand and vascular access devices including the Vortex ports...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.